Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
11.38
+0.05 (0.44%)
At close: Feb 27, 2026, 4:00 PM EST
11.17
-0.21 (-1.85%)
After-hours: Feb 27, 2026, 6:21 PM EST
IART Stock Forecast
Stock Price Forecast
The 6 analysts that cover IART stock have a consensus rating of "Hold" and an average price target of $14.83, which forecasts a 30.32% increase in the stock price over the next year. The lowest target is $11 and the highest is $25.
Price Target: $14.83 (+30.32%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for IART stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 2 | 3 | 3 | 3 | 3 |
| Sell | 3 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $13 → $12 | Hold | Maintains | $13 → $12 | +5.45% | Feb 27, 2026 |
| Truist Securities | Truist Securities | Hold Reiterates $15 → $13 | Hold | Reiterates | $15 → $13 | +14.24% | Nov 3, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $12 → $11 | Strong Sell | Maintains | $12 → $11 | -3.34% | Oct 31, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $12 → $13 | Sell | Maintains | $12 → $13 | +14.24% | Oct 31, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | +31.81% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
1.71B
from 1.64B
Increased by 4.45%
Revenue Next Year
1.77B
from 1.71B
Increased by 3.57%
EPS This Year
2.40
from -6.74
EPS Next Year
2.68
from 2.40
Increased by 11.74%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.8B | 1.9B | |
| Avg | 1.7B | 1.8B | |
| Low | 1.6B | 1.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.1% | 9.0% | |
| Avg | 4.4% | 3.6% | |
| Low | -1.1% | -2.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.68 | 3.06 | |
| Avg | 2.40 | 2.68 | |
| Low | 2.22 | 2.44 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 27.4% | |
| Avg | - | 11.7% | |
| Low | - | 1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.